Update: Drug therapy for ulcerative colitis

被引：0
|
作者：
Sonnenberg, Elena [1 ,4 ]
Siegmund, Britta [2 ,3 ,4 ]
Weidinger, Carl [1 ]
机构：
[1] Charite Univ Med Berlin, Med Klin Gastroenterol Infektiol & Rheumatol, Arbeitsbereich Ernahrungsmed, Campus Benjamin Franklin, Berlin, Germany
[2] Charite Univ Med Berlin, Med Klin Gastroenterol Infektiol & Rheumatol, Campus Benjamin Franklin, Berlin, Germany
[3] Charite Univ Med Berlin, Med, Berlin, Germany
[4] Charite Univ Med Berlin, Med Klin Gastroenterol Infektiol & Rheumatol, Hindenburgdamm 30, D-12203 Berlin, Germany
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2025年 / 150卷 / 08期
关键词：
MAINTENANCE THERAPY; DOUBLE-BLIND; INDUCTION;
D O I：
10.1055/a-2368-7090
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Despite advances in drug therapy for ulcerative colitis, rates of primary and/or secondary treatment failure are still considerable. Numerous new agents have been developed and approved in recent years. In this article, we discuss case-based decision-making processes for selecting appropriate anti-inflammatory treatments in UC patients and summarize the principles of the various therapeutic strategies.
引用
收藏
页码：412 / 418
页数：7
相关论文
共 50 条
12345